CytoSorbents (CTSO, Financial) has retained its "Buy" rating from D. Boral Capital, as confirmed by analyst Jason Kolbert. The current price target for the company remains unchanged at $10.00 USD. This decision reflects a consistent outlook for CytoSorbents, maintaining the prior assessment set by the analyst.
The analysis and rating update provided by D. Boral Capital and Jason Kolbert supports a stable perspective on CytoSorbents (CTSO, Financial), with no alterations in the price target or rating status since the previous evaluation. The consistent "Buy" rating suggests optimism about the company's potential in the market.
Investors following CytoSorbents (CTSO, Financial) can note that Jason Kolbert's analysis indicates continuous confidence in reaching the $10.00 USD price target. As of the latest update on May 15, 2025, the figures and recommendation remain steady, aligning with prior predictions.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 2 analysts, the average target price for CytoSorbents Corp (CTSO, Financial) is $7.00 with a high estimate of $10.00 and a low estimate of $4.00. The average target implies an upside of 699.63% from the current price of $0.88. More detailed estimate data can be found on the CytoSorbents Corp (CTSO) Forecast page.
Based on the consensus recommendation from 2 brokerage firms, CytoSorbents Corp's (CTSO, Financial) average brokerage recommendation is currently 2.5, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
Based on GuruFocus estimates, the estimated GF Value for CytoSorbents Corp (CTSO, Financial) in one year is $1.79, suggesting a upside of 104.48% from the current price of $0.8754. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the CytoSorbents Corp (CTSO) Summary page.
